BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 22744334)

  • 1. Enteral nutrients potentiate glucagon-like peptide-2 action and reduce dependence on parenteral nutrition in a rat model of human intestinal failure.
    Brinkman AS; Murali SG; Hitt S; Solverson PM; Holst JJ; Ney DM
    Am J Physiol Gastrointest Liver Physiol; 2012 Sep; 303(5):G610-22. PubMed ID: 22744334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enteral nutrients potentiate the intestinotrophic action of glucagon-like peptide-2 in association with increased insulin-like growth factor-I responses in rats.
    Liu X; Murali SG; Holst JJ; Ney DM
    Am J Physiol Regul Integr Comp Physiol; 2008 Dec; 295(6):R1794-802. PubMed ID: 18832087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic effect of supplemental enteral nutrients and exogenous glucagon-like peptide 2 on intestinal adaptation in a rat model of short bowel syndrome.
    Liu X; Nelson DW; Holst JJ; Ney DM
    Am J Clin Nutr; 2006 Nov; 84(5):1142-50. PubMed ID: 17093168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colonic GLP-2 is not sufficient to promote jejunal adaptation in a PN-dependent rat model of human short bowel syndrome.
    Koopmann MC; Liu X; Boehler CJ; Murali SG; Holst JJ; Ney DM
    JPEN J Parenter Enteral Nutr; 2009; 33(6):629-38; discussion 638-9. PubMed ID: 19644131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained glucagon-like peptide-2 infusion is required for intestinal adaptation, and cessation reverses increased cellularity in rats with intestinal failure.
    Koopmann MC; Chen X; Holst JJ; Ney DM
    Am J Physiol Gastrointest Liver Physiol; 2010 Dec; 299(6):G1222-30. PubMed ID: 20864657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whey protein potentiates the intestinotrophic action of glucagon-like peptide-2 in parenterally fed rats.
    Liu X; Murali SG; Holst JJ; Ney DM
    Am J Physiol Regul Integr Comp Physiol; 2009 Nov; 297(5):R1554-62. PubMed ID: 19776251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel effect of glucagon-like peptide-2 for hepatocellular injury in a parenterally fed rat model of short bowel syndrome.
    Yano K; Kaji T; Onishi S; Machigashira S; Nagai T; Harumatsu T; Yamada K; Yamada W; Muto M; Nakame K; Mukai M; Ieiri S
    Pediatr Surg Int; 2019 Dec; 35(12):1345-1351. PubMed ID: 31555865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exogenous glucagon-like peptide-2 (GLP-2) augments GLP-2 receptor mRNA and maintains proglucagon mRNA levels in resected rats.
    Koopmann MC; Nelson DW; Murali SG; Liu X; Brownfield MS; Holst JJ; Ney DM
    JPEN J Parenter Enteral Nutr; 2008; 32(3):254-65. PubMed ID: 18443137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential Effects on Intestinal Adaptation Following Exogenous Glucagon-Like Peptide 2 Therapy With and Without Enteral Nutrition in Neonatal Short Bowel Syndrome [Formula: see text].
    Lim DW; Diané A; Muto M; Vine DF; Nation PN; Wizzard PR; Sigalet DL; Bigam DL; Pencharz PB; Turner JM; Wales PW
    JPEN J Parenter Enteral Nutr; 2017 Feb; 41(2):156-170. PubMed ID: 27660290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucagon-like peptide-2 induces rapid digestive adaptation following intestinal resection in preterm neonates.
    Vegge A; Thymann T; Lund P; Stoll B; Bering SB; Hartmann B; Jelsing J; Qvist N; Burrin DG; Jeppesen PB; Holst JJ; Sangild PT
    Am J Physiol Gastrointest Liver Physiol; 2013 Aug; 305(4):G277-85. PubMed ID: 23764891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-like growth factor I and glucagon-like peptide-2 responses to fasting followed by controlled or ad libitum refeeding in rats.
    Nelson DW; Murali SG; Liu X; Koopmann MC; Holst JJ; Ney DM
    Am J Physiol Regul Integr Comp Physiol; 2008 Apr; 294(4):R1175-84. PubMed ID: 18256135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of exogenous glucagon-like peptide-2 and distal bowel resection on intestinal and systemic adaptive responses in rats.
    Lai SW; de Heuvel E; Wallace LE; Hartmann B; Holst JJ; Brindle ME; Chelikani PK; Sigalet DL
    PLoS One; 2017; 12(7):e0181453. PubMed ID: 28738080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergy of glucagon-like peptide-2 and epidermal growth factor coadministration on intestinal adaptation in neonatal piglets with short bowel syndrome.
    Lim DW; Levesque CL; Vine DF; Muto M; Koepke JR; Nation PN; Wizzard PR; Li J; Bigam DL; Brubaker PL; Turner JM; Wales PW
    Am J Physiol Gastrointest Liver Physiol; 2017 Apr; 312(4):G390-G404. PubMed ID: 28104586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of bowel rehabilitative therapy on structural adaptation of remnant small intestine: animal experiment.
    Zhou X; Li YX; Li N; Li JS
    World J Gastroenterol; 2001 Feb; 7(1):66-73. PubMed ID: 11819735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Long-Acting GLP-2 Analogue, FE 203799 (Apraglutide), Enhances Adaptation and Linear Intestinal Growth in a Neonatal Piglet Model of Short Bowel Syndrome with Total Resection of the Ileum.
    Slim GM; Lansing M; Wizzard P; Nation PN; Wheeler SE; Brubaker PL; Jeppesen PB; Wales PW; Turner JM
    JPEN J Parenter Enteral Nutr; 2019 Sep; 43(7):891-898. PubMed ID: 30614011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucagon-like peptide-2 induces intestinal adaptation in parenterally fed rats with short bowel syndrome.
    Martin GR; Wallace LE; Sigalet DL
    Am J Physiol Gastrointest Liver Physiol; 2004 Jun; 286(6):G964-72. PubMed ID: 14962847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucagon-like peptide-2 induces a specific pattern of adaptation in remnant jejunum.
    Sigalet DL; Bawazir O; Martin GR; Wallace LE; Zaharko G; Miller A; Zubaidi A
    Dig Dis Sci; 2006 Sep; 51(9):1557-66. PubMed ID: 16927140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of polymeric formula vs elemental formula in neonatal piglets with short bowel syndrome.
    Hua Z; Turner JM; Mager DR; Sigalet DL; Wizzard PR; Nation PN; Ball RO; Pencharz PB; Wales PW
    JPEN J Parenter Enteral Nutr; 2014 May; 38(4):498-506. PubMed ID: 23690158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute effects of the glucagon-like peptide 2 analogue, teduglutide, on intestinal adaptation in short bowel syndrome.
    Thymann T; Stoll B; Mecklenburg L; Burrin DG; Vegge A; Qvist N; Eriksen T; Jeppesen PB; Sangild PT
    J Pediatr Gastroenterol Nutr; 2014 Jun; 58(6):694-702. PubMed ID: 24399211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exogenous glucagon-like peptide-2 improves outcomes of intestinal adaptation in a distal-intestinal resection neonatal piglet model of short bowel syndrome.
    Suri M; Turner JM; Sigalet DL; Wizzard PR; Nation PN; Ball RO; Pencharz PB; Brubaker PL; Wales PW
    Pediatr Res; 2014 Oct; 76(4):370-7. PubMed ID: 24995913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.